Description
Elunate (fruquintinib) is a kinase inhibitor used for the treatment of adult patients with metastatic colorectal cancer (mCRC) who have been previously treated with fluoropyrimidine‑, oxaliplatin‑, and irinotecan‑based chemotherapy, an anti‑VEGF therapy, and, if RAS wild-type and medically appropriate, an anti-EGFR therapy.
Additional information
| Brand | Elunate |
|---|---|
| Generic name | Fruquintinib capsules |
| Form | Capsules |
| Strength | 1mg |
| Manufacturer | Hutchmed Ltd. |
| Documents | Either PO or prescription |
| Storage | 20-25°C temperature |
| Packing | 21 capsules/pack |
Reviews
There are no reviews yet.